SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Byström Sanna)
 

Sökning: WFRF:(Byström Sanna) > (2022) > Circulating protein...

Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer

Thomas, Cecilia Engel (författare)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
Dahl, Leo, 1995- (författare)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
Byström, Sanna (författare)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
visa fler...
Chen, Yan (författare)
Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, SE-17177 Stockholm, Sweden.;Karolinska Inst, Dept Med, Stockholm, Sweden.
Uhlén, Mathias (författare)
KTH,Science for Life Laboratory, SciLifeLab,Systembiologi
Mälarstig, Anders (författare)
Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, SE-17177 Stockholm, Sweden.;Karolinska Inst, Dept Med, Stockholm, Sweden.
Czene, Kamila (författare)
Karolinska Institutet
Hall, Per (författare)
Karolinska Institutet
Schwenk, Jochen M. (författare)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik
Gabrielson, Marike (författare)
Karolinska Institutet
visa färre...
 (creator_code:org_t)
Elsevier BV, 2022
2022
Engelska.
Ingår i: Translational Oncology. - : Elsevier BV. - 1944-7124 .- 1936-5233. ; 17, s. 101339-
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Accessible risk predictors are crucial for improving the early detection and prognosis of breast cancer. Blood samples are widely available and contain proteins that provide important information about human health and disease, however, little is still known about the contribution of circulating proteins to breast cancer risk prediction. We profiled EDTA plasma samples collected before diagnosis from the Swedish KARMA breast cancer cohort to evaluate circulating proteins as molecular predictors. A data-driven analysis strategy was applied to the molecular phenotypes built on 700 circulating proteins to identify and annotate clusters of women. The unsupervised analysis of 183 future breast cancer cases and 366 age-matched controls revealed five stable clusters with distinct proteomic plasma profiles. Among these women, those in the most stable cluster (N = 19; mean Jaccard index: 0.70 +/- 0.29) were significantly more likely to have used menopausal hormonal therapy (MHT), get a breast cancer diagnosis, and were older compared to the remaining clusters. The circulating proteins associated with this cluster (FDR < 0.001) represented physiological processes related to cell junctions (F11R, CLDN15, ITGAL), DNA repair (RBBP8), cell replication (TJP3), and included proteins found in female reproductive tissue (PTCH1, ZP4). Using a data-driven approach on plasma proteomics data revealed the potential long-lasting molecular effects of menopausal hormonal therapy (MHT) on the circulating proteome, even after women had ended their treatment. This provides valuable insights concerning proteomics efforts to identify molecular markers for breast cancer risk prediction.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Breast cancer
Risk prediction
Plasma proteomics
Affinity proteomics
Karma cohort
Archetypal analysis
Clustering
Patient stratification
Menopausal hormonal therapy

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy